Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Apricus Biosciences, Inc.

NASDAQ: APRIHealthcare / Drug Manufacturers - Other / USA
0.260000.00Vol 483 3551Y Perf -89.80%
Jan 17th, 2019 16:00
BID0.2600 ASK0.2600
Open0.2600 Previous Close0.2600
Pre-Market- After-Trading0.25
 - -%  -0.01 -3.85%
Target Price
2.65 
Analyst Rating
— 0.00
Potencial %
919.23 
Finscreener Ranking
★★+ —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★★     52.53
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     47.98
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Buy
Price Range Ratio 52wk %
2.53 
Earnings Date
7th Mar 2019

Today's Price Range

0.25000.2700

 

52wk Range

0.18003.34

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
13.04%
3 Months
-23.53%
6 Months
-35.00%
1 Year
-89.80%
3 Years
-98.00%
5 Years
-98.81%

Quotes

Name / TickerPriceChg.Chg.%
APRI0.26000.00000.00
AAPL155.860.92000.59
GOOG1 089.908.93000.83
MSFT106.120.74000.70
XOM72.130.49000.68
WFC49.230.29000.59
JNJ129.091.05000.82
FB148.300.76000.52
GE9.140.16001.78
JPM102.920.42000.41
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.70
Current Ratio
3.80
Long Term Debt to Total Capital
-
Total Debt to Equity
0.00
Interest Coverage
-108.80
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
79.20
EBIT Margin
-697.20
EBITDA Margin
-677.00
Pre-tax Profit Margin
-305.20
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
0.70
PB Ratio
1.86
PS Ratios
79.92
Price to Cash Flow
26.00
Price to Free Cash Flow
-1.20
Cash Flow Per Share
-0.46
Price to Tangible Book
1.86
Book Value per Share
0.15
Enterprise Value (in ths.)
2 364
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-6 996.66
ROE last 12 Months
-188.50
Return on Assets (5Y Avg)
-180.33
ROA last 12 Months
-136.68
Return on Capital (5Y Avg)
-
ROC last 12 Months
-188.50
Return on invested Capital Q
-60.40
Return on invested Capital Y
-45.76
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-53.21
Revenue Growth 5 Years
-27.17
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.12-
Q02 2018--0.10-
Q01 2018-0.10-0.14-40.00
Q04 2017-0.13-0.16-23.08
Q03 2017-0.15-0.30-100.00
Q02 2017-0.17-0.1511.76
Q01 20171.24-0.44-135.48
Q04 20160.01-0.04-500.00
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.100.00-
9/2018 QR-0.100.00-
12/2018 FY-0.400.00-
12/2018 FY-0.39-130.47Negative
Next Report Date7th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume483 355
Shares Outstanding (in ths.)28 170
Trades Count1 547
Dollar Volume125 725
Avg. Volume643 329
Avg. Weekly Volume515 490
Avg. Monthly Volume536 032
Avg. Quarterly Volume605 301

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

46%54%

Bearish Bullish

71%29%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0
0 (0.00 %)
0 (0.00 %)
Hold
0
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0
0 (0.00 %)
0 (0.00 %)
Strong Sell
0
0 (0.00 %)
0 (0.00 %)
Rating-Hold
3.00
Hold
3.00

There are no comments yet.

News